HOUSTON: AICure today announced the appointments of Anand Ramaswamy as Chief Product Officer and Olinka Greene as Director of Quality Assurance and Management. Together, these leadership appointments support AICure's continued expansion of its AI-powered medication adherence platform, recently launched WeightVerify for remote weight verification and monitoring, and enterprise white-label solutions for life sciences, healthcare organizations, and digital health partners across our product lines.

Building on the company's momentum in AI-powered medication adherence and its expanding portfolio of trusted patient-generated health data solutions, AICure is investing in product innovation and quality leadership to support pharmaceutical companies, biotechnology organizations, contract research organizations (CROs), healthcare providers, and digital health partners.

CEO Statement

“As healthcare continues to shift toward intelligent, remote patient engagement, innovation and quality must advance together,” said Sabina Chadha, Chief Executive Officer of AICure. “Anand's vision for AI-driven product innovation and Olinka's deep expertise in quality systems and regulatory excellence position AICure to expand our medication adherence platform, remote weight verification capabilities, and enterprise white-label offerings while maintaining the highest standards of quality and compliance.”

Anand Ramaswamy, Chief Product Officer

Ramaswamy brings more than 25 years of executive leadership in healthcare technology, artificial intelligence, enterprise software, and digital transformation. He will lead AICure's product strategy, AI innovation, user experience, and platform roadmap, accelerating development of intelligent medication adherence, patient engagement, remote monitoring, and enterprise solutions.

Olinka Greene, Director of Quality Assurance and Management

Greene brings more than 20 years of leadership in quality assurance, validation, and regulatory compliance across life sciences and SaaS organizations. Her expertise includes FDA 21 CFR Part 11 compliance, GxP quality systems, computerized system validation, CAPA, audit readiness, supplier quality, and enterprise Quality Management Systems. She previously held quality leadership roles at AICure, Akyrian, and Medidata Solutions. In her new role, Greene will lead quality assurance, validation, compliance, and quality management initiatives supporting AICure's expanding portfolio of AI-powered medication adherence, remote weight verification, and enterprise white-label products.

“I am excited to rejoin AICure and help scale a quality organization that supports innovation while ensuring the highest standards of compliance, reliability, and customer confidence,” said Greene.

About AICure

AICure is a leading provider of AI-powered medication adherence and patient engagement solutions. Its platform combines artificial intelligence and computer vision to deliver trusted patient-generated health data, support remote weight verification and monitoring through its recent launch of WeightVerify, improve treatment adherence, and enable enterprise white-label solutions across its product lines for pharmaceutical companies, biotechnology organizations, CROs, healthcare providers, and digital health organizations.

Fonte: Business Wire